Financial Statements · Financial Reporting
Swixx Biopharma OÜ
Official identifier 12741121Record date 31 Dec 2024
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2024
- Period start
- 1 Jan 2024
- Submitted date
- 27 Jun 2025
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Bilanss, detailne | Assets | 1,206,320 |
| Bilanss, detailne | Cash and cash equivalents | 267,356 |
| Bilanss, detailne | Current assets | 1,183,321 |
| Bilanss, detailne | Current liabilities | 518,422 |
| Bilanss, detailne | Equity | 687,898 |
| Bilanss, detailne | Share capital at nominal value | 2,500 |
| Bilanss, detailne | Non-current assets | 22,999 |
| Bilanss, detailne | Retained earnings (loss) from previous periods | 478,545 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -11,829 |
| Income statement scheme 1 | Labour costs | -2,380,315 |
| Income statement scheme 1 | Revenue | 4,001,491 |
| Income statement scheme 1 | Annual period profit / loss | 206,603 |
| Income statement scheme 1 | Operating profit (loss) | 206,511 |
| Income statement scheme 1 | Profit (loss) before income tax | 206,603 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 478,545 |
| Note: Labour costs | Employees | 25 |
| Note: Labour costs | Labour costs | 2,380,315 |
Linked company
Company: Swixx Biopharma OÜ